DE69729120D1 - Arzneipräparat und verfahren zur behandlung und vorbeugung von fybromyalgie und des chronischen ermüdungssyndrom - Google Patents

Arzneipräparat und verfahren zur behandlung und vorbeugung von fybromyalgie und des chronischen ermüdungssyndrom

Info

Publication number
DE69729120D1
DE69729120D1 DE69729120T DE69729120T DE69729120D1 DE 69729120 D1 DE69729120 D1 DE 69729120D1 DE 69729120 T DE69729120 T DE 69729120T DE 69729120 T DE69729120 T DE 69729120T DE 69729120 D1 DE69729120 D1 DE 69729120D1
Authority
DE
Germany
Prior art keywords
chronic fatigue
fatigue syndrome
preparation
fybromyalgia
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69729120T
Other languages
English (en)
Other versions
DE69729120T2 (de
Inventor
Carl-Gerhard Gottfries
Bjoern Regland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOTTFRIESMOTTAGNINGEN MOELN AB
Original Assignee
GOTTFRIESMOTTAGNINGEN MOELN AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOTTFRIESMOTTAGNINGEN MOELN AB filed Critical GOTTFRIESMOTTAGNINGEN MOELN AB
Application granted granted Critical
Publication of DE69729120D1 publication Critical patent/DE69729120D1/de
Publication of DE69729120T2 publication Critical patent/DE69729120T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69729120T 1996-12-30 1997-12-23 Arzneipräparat und verfahren zur behandlung und vorbeugung von fybromyalgie und des chronischen ermüdungssyndrom Expired - Lifetime DE69729120T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9604844 1996-12-30
SE9604844A SE9604844D0 (sv) 1996-12-30 1996-12-30 Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom
PCT/SE1997/002208 WO1998029133A1 (en) 1996-12-30 1997-12-23 Pharmaceutical preparation and method for treatment and prevention of fibromyalgia and chronic fatigue

Publications (2)

Publication Number Publication Date
DE69729120D1 true DE69729120D1 (de) 2004-06-17
DE69729120T2 DE69729120T2 (de) 2005-04-28

Family

ID=20405192

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729120T Expired - Lifetime DE69729120T2 (de) 1996-12-30 1997-12-23 Arzneipräparat und verfahren zur behandlung und vorbeugung von fybromyalgie und des chronischen ermüdungssyndrom

Country Status (10)

Country Link
US (1) US6368590B1 (de)
EP (1) EP0964700B1 (de)
AT (1) ATE266419T1 (de)
AU (1) AU5582198A (de)
DE (1) DE69729120T2 (de)
DK (1) DK0964700T3 (de)
ES (1) ES2221077T3 (de)
PT (1) PT964700E (de)
SE (1) SE9604844D0 (de)
WO (1) WO1998029133A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE523136C2 (sv) * 1999-12-21 2004-03-30 Gottfriesmottagningen Ab Användning av stafylokockbakterier i samband med behandling av irritable bowelsyndrome
CN102281894A (zh) * 2008-11-13 2011-12-14 菲利普.科曼斯 睡眠中呼吸努力相关觉醒和打鼾的治疗以及药剂
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2078019C (en) * 1991-09-13 2002-08-27 Siegbert Heinrich Bissbort Substance or composition and uses thereof
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease

Also Published As

Publication number Publication date
EP0964700A1 (de) 1999-12-22
DK0964700T3 (da) 2004-09-06
US6368590B1 (en) 2002-04-09
SE9604844D0 (sv) 1996-12-30
WO1998029133A1 (en) 1998-07-09
PT964700E (pt) 2004-09-30
ES2221077T3 (es) 2004-12-16
EP0964700B1 (de) 2004-05-12
AU5582198A (en) 1998-07-31
DE69729120T2 (de) 2005-04-28
ATE266419T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
HUP9801283A2 (hu) Tomoxetin alkalmazása figyelemhiány/hiperaktivitás betegség kezelésére alkalmas gyógyszerkészítmény előállítására
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE69526934T2 (de) Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere
ATE307608T1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
IL173346A0 (en) Treatment of dependence withdrawal
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
ATE213417T1 (de) Progesteronantagonist und gestagen zur behandlung der endometriose und leiomyomata uteri
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
YU48559B (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ATE66149T1 (de) Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
DE69729120D1 (de) Arzneipräparat und verfahren zur behandlung und vorbeugung von fybromyalgie und des chronischen ermüdungssyndrom
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
DE69930624D1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
DE60036382D1 (de) Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
HUP9801628A2 (hu) Artritisz elleni gyógyászati készítmények
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
饶忠东 et al. Observation on the therapeutic effect of auricular plaster for treatment of 135 cases of motion sickness
WO2004078145B1 (en) Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis
RU94041584A (ru) Способ лечения язвенной болезни

Legal Events

Date Code Title Description
8364 No opposition during term of opposition